9 July 2021
Latham & Watkins Advises Alpha Tau on Business Combination with Healthcare Capital Corp.
Advising firms
Deal team
10 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Eyal Orgad Lead | Latham & Watkins LLP | Partner | M&A | New York |
| Joshua Kiernan Lead | Latham & Watkins LLP | Partner | capital markets | London |
| Michael Vardanian | Latham & Watkins LLP | Counsel | M&A | New York |
| Serena Shi | Latham & Watkins LLP | Associate | M&A | New York |
| Charles Shier | Latham & Watkins LLP | Associate | M&A | New York |
| Nathan Ajiashvili | Latham & Watkins LLP | Partner | capital markets | New York |
| Michael Rosenberg | Latham & Watkins LLP | Counsel | capital markets | New York |
| Danny Shulman | Latham & Watkins LLP | Associate | capital markets | Houston |
| Pardis Zomorodi | Latham & Watkins LLP | Partner | tax | Los Angeles |
| Sam Yang | Latham & Watkins LLP | Associate | tax | New York |
Stated terms
- Stated value
- USD 1bn (approximately US$1 billion)
- What the figure measures
- Enterprise value
- Client
- Alpha Tau Medical LimitedBuy-side
- Counterparties
- Healthcare Capital Corp. (Sell-side)